Is This The Next Drug Shortage Rfk Jrs Supporters Are Making It More Likely

1 / 5

2 / 5

3 / 5

4 / 5

5 / 5

❮ ❯

Worries over the market for the new glp-1 obesity drugs have been stirring since last month, when third-quarter sales of eli lilly’s zepbound and mounjaro came in well behind expectations. As his pick to lead the … · the eu will need to strengthen its pharmaceutical manufacturing base to reduce dependence on external suppliers and ensure strategic autonomy. What’s more, the … Centers for medicare & medicaid services is seeking to bring more transparency to drug price negotiations, indicating plans to move forward with the second … · 340b program reforms and pbm reforms are likely priorities, with bipartisan support for transparency and compensation delinking. · like many political leaders on both sides of the aisle, kennedy has signaled his support for capping drug costs. “legislators should cap drug prices so that companies can’t charge americans substantially more than europeans pay,” kennedy wrote in a wall street journal op-ed in september. · shares in several pharmaceutical and biotechnology companies dropped sharply after president-elect trump announced robert f. Kennedy jr. , said during his senate confirmation hearing yesterday that substance use services were a priority” to him should. · this month, donald trump floated the idea of slapping 25pc tariffs on pharmaceutical imports, threatening to push up costs for global drugmakers. May play a significant advisory … · president donald trump’s nominee for health secretary, robert f. Major pharmaceutical companies face unprecedented challenges and opportunities in drug development, with rising r&d costs offset by breakthroughs in ai-assisted research and … Kennedy jr. ’s anticipated exit from the presidential race and rumored endorsement of former president donald trump might help trump in the race by a tiny margin, according to some. · while the standard for approval of a new drug (including vaccines) is set by statute, fda reviewers have significant scientific leeway when considering data submitted to support … Direct drug exports